EXPRESSION OF IL-6 RECEPTOR IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE OF VARYING SEVERITY


如何引用文章

全文:

作者简介

T Vitkina

Vladivostok Branch of «Far Eastern Scientific Center of Physiology and Pathology of Respiration» - Research Institute of Medical Climatology and Rehabilitation Treatment

Yu Denisenko

Vladivostok Branch of «Far Eastern Scientific Center of Physiology and Pathology of Respiration» - Research Institute of Medical Climatology and Rehabilitation Treatment

T Novgorodtseva

Vladivostok Branch of «Far Eastern Scientific Center of Physiology and Pathology of Respiration» - Research Institute of Medical Climatology and Rehabilitation Treatment

K Sidletskaya

Vladivostok Branch of «Far Eastern Scientific Center of Physiology and Pathology of Respiration» - Research Institute of Medical Climatology and Rehabilitation Treatment

参考

  1. Лобанова Е.Г., Калинина Е.П., Денисенко Ю.К. Особенности содержания цитокинов Th1- и Th 17-лимфоцитов у лиц с хронической обструктивной болезнью легких // Медицинская иммунология. - 2016. - Т.18, №3. - С. 287-290.
  2. Лобанова Е.Г., Калинина Е.П., Виткина Т.И., Денисенко Ю.К., Назаренко А.В., Юренко А.В. Т-клеточная иммунорегуляция и уровень цитокинов у больных хронической обструктивной болезнью легких // Медицинская иммунология. - 2015. - Т.17, №3s. - С. 69-70.
  3. Реброва О. Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. - М.: МедиаСфера, 2002. - 312 с.
  4. Global initiative for chronic obstructive lung disease: global strategy for the diagnosis, management, and prevention of chronic obctructive pulmonary disease, 2014 [Electronic resourse]. URL: http://www.goldcopd. org/uploads/users/ files/GOLD_Report_2014_Jun11.pdf.
  5. Goldsby R., Kindt T., Osborne B., Kuby J. Immunology: 5th ed. W. H. Freeman, 2003, 603 p.
  6. Kalinina E., Karaman Yu., Vitkina T., Lobanova E., Novgorodtseva T., Antonyuk M., Gvozdenko T., Knyshova V. and Nazarenko A. The mechanisms of the regulation of immune response in patients with comorbidity of chronic obstructive pulmonary disease and asthma. Canadian Respiratory Journal, 2016, Vol. 2016, pp. 8.
  7. Liang R., Zhang W., Song Y. M. Levels of leptin and IL-6 in lungs and blood are associated with the severity of chronic obstructive pulmonary disease in patients and rat models. Molecular medicine reports, 2013, Т. 7, no. 5, pp. 1470-1476.
  8. Rincon M., Irvin C.G. Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases. Int. J. Biol. Sci., 2012, Vol. 8, no. 9, pp. 1281-1290.
  9. Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int. J. Biol. Sci., 2012, Т. 8, no. 9, pp. 1237-1247.
  10. Schaper F., Rose-John S. Interleukin-6: biology, signaling and strategies of blockade. Cytokine & growth factor reviews, 2015, Т. 26, no. 5, pp. 475-487.
  11. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochimica et Biophysica Acta-Molecular Cell Research, 2011, Vol. 1813, no. 5, pp. 878888.
  12. Toumpanakis D., Vassilakopoulos T. Molecular mechanisms of action of Interleukin-6 (IL-6). Pneumon, 2007, Т. 20, no. 1, pp. 154-67.
  13. Vitkina T.I., Yankova V.I., Gvozdenko T.A., Nazarenko A.V., Golokhvast K.S., Kuznetsov V.L., Krasnikov D.V., Chaika V.V., Smagin S.V., Tsatsakis A.M., Engin A.B., Karakitsios S.P., Sarigiannis D.A. The impact of multi-walled carbon nanotubes with different amount of metallic impurities on immunometabolic parameters in healthy volunteers. Food and Chemical Toxicology, 2016, Т. 87, pp. 138-147.
  14. Vitkina T.I., Denisenko Yu.K., Davydova K.A.The changes in the profile of cytokines in progressing chronic obstructive pulmonary disease. International Research Journal, 2016, Vol.49, no. 7-3, pp. 6-8.
  15. Young R. P., Hopkins R. J. Interleukin-6 and statin therapy: potential role in the management of COPD. Respiratory research, 2013, Т. 14, no. 1, pp. 1.

版权所有 © Pharmarus Print Media, 2017

##common.cookie##